Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous methylprednisolone versus oral prednisone in severe edema minimal change nephrotic syndrome
ChiCTR-TRC-13003783Phase 4Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methylprednisolone and prednisone in nephrosis (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoints: Urine protein and Serum albumin. Started Jul 2013; status: completed.
02
Drugs
methylprednisoloneprednisone
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR-TRC-13003783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003783.